English TOP- Noile-Immune Biotech Inc.

News

2024/10/04: Exhibition by Noile-Immune at Japan Healthcare Venture Summit 2024 co-held with BioJapan 2024; Noile-Immune will exhibit at the Japan Healthcare Venture Summit (JHVS), which will be co-held with BioJapan 2024 at Pacifico Yokohama from Wednesday, October 9 to Friday, October 11, 2024. At the exhibition booth (Booth No.: V-62), Noile-Immune will introduce its proprietary PRIME technology, an innovative approach to enhance the therapeutic effects of immune cell therapy, and will make a presentation at the "JHVS SHOWCASE" held on the stage at the JHVS venue (Wednesday, October 9, 11:00-12:00 part). In addition, Noile-Immune will participate in the 1 on 1 meetings using the partnering system.

2024/09/27: Publication of Research Article on Therapeutic Efficacy of CAR-T Cells with Noile-Immune’s PRIME technology in Intractable Solid Tumors (Japanese version already released on September 13)

2024/09/25: Notice of Business Collaboration with Takara Bio in the Development of NIB103

2024/06/28: Notice of Re-prioritization of In-house Drug Discovery Pipelines and Change in Use of Funds Raised at the Time of Listing